Healthcare technology company Koneska is extending its contribution to critical neuroscience research by collaborating with an academic partnership program.
Digital biomarker company Koneksa has launched the first collaboration in the Koneska Academic Partnership Program for Parkinson’s Disease (KAPP-PD) to incorporate its Neuroscience Toolkit into research programs.